Cerner Has Acquired Labotix Automation Inc.

Cerner Has Acquired Labotix Automation Inc.

Combination Will Create the Most Comprehensive Set of Lab Automation

KANSAS CITY, Mo. and PETERBOROUGH, Ontario, March 18, 2013 (GLOBE NEWSWIRE) --
Cerner (Nasdaq:CERN) today announced it has acquired Labotix^® Automation
Inc., a leading provider of flexible, open automation solutions for the
clinical laboratory setting.

The combination of Cerner Millennium^®, Cerner Copath, and Labotix' Automation
will create the most comprehensive set of capabilities on the market to
support high volume testing.

Cerner's mission is to contribute to the systemic improvement of health care
delivery and the health of communities. "By aligning Labotix and Cerner^®
solutions, Cerner is uniquely positioned with its automation options to
support clients focusing on increasing laboratory processing capacity while
reducing error," said Dr. John David Nolen, Managing Director of Laboratory
Medicine for Cerner. "These capabilities are, and increasingly will be,
important to organizations which have a business model for high volume or
centralized laboratory business models."

Labotix Automation is an open automation solution, meaning it will work with
all best of breed devices currently on the market. With installations around
the world that have been operating and evolving for more than twenty years,
Labotix Automation has the experience, expertise and reliability necessary to
meet the needs of any size laboratory.

Since its inception in 1991, Labotix Automation has steadily grown its
presence in the laboratory automation market. Cerner, an industry-leading
health care company, will immediately offer Labotix Automation solutions to
clients around the world and expects to drive increased value for laboratories
through integration with Cerner's platforms.

"Cerner's dedication to providing clinical organizations with reliable,
flexible and continuous innovation, combined with Labotix' automation
solutions will further enable clinical laboratories to increase accuracy and
efficiency to deliver better outcomes for individuals," said John Gustafson,
CEO of Labotix Automation.

The acquisition is not expected to have a material impact on Cerner's 2013
financial results.

About Cerner

Cerner is contributing to the systemic change of health and care delivery. For
more than 30 years Cerner has been executing its vision to make health care
safer and more efficient. We started with the foundation of digitizing paper
processes and now offer the most comprehensive array of information software,
professional services, medical device integration, remote hosting and employer
health and wellness services. Cerner systems are used by everyone from
individual consumers, to single-doctor practices, hospitals, employers and
entire countries. Taking what we've learned over more than three decades,
Cerner is building on the knowledge that is in the system to support
evidence-based clinical decisions, prevent medical errors and empower patients
in their care.

Cerner^® solutions are licensed by approximately 10,000 facilities around the
world, including more than 2,700 hospitals; 4,150 physician practices; 45,000
physicians; 550 ambulatory facilities, such as laboratories, ambulatory
centers, behavioral health centers, cardiac facilities, radiology clinics and
surgery centers; 800 home health facilities; 45 employer sites and 1,750
retail pharmacies.

Certain trademarks, service marks and logos (collectively, the "Marks") set
forth herein are owned by Cerner Corporation and/or its subsidiaries in the
United States and certain other countries throughout the world. All other
non-Cerner Marks are the property of their respective owners. Nasdaq:CERN. For
more information about Cerner, please visit, Twitter,
Facebookand YouTube.

This release contains forward-looking statements that involve a number of
risks and uncertainties. It is important to note that the Company's
performance, and actual results, financial condition or business could differ
materially from those expressed in such forward-looking statements. The words
"will create" "expects" and "is not expected" or the negative of these words,
variations thereof or similar expressions are intended to identify such
forward-looking statements. Factors that could cause or contribute to such
differences include, but are not limited to: the possibility of
product-related liabilities; potential claims for system errors and
warranties; the possibility of interruption at ourclient support facilities;
our proprietary technology may be subject to claims for infringement or
misappropriation of intellectual property rights of others, or may be
infringed or misappropriated by others; risks associated with our non-U.S.
operations; risks associated with our recruitment and retention of key
personnel; risks related to our dependence on third party suppliers; risks
inherent with business acquisitions; changing political, economic, regulatory
and judicial influences; government regulation; significant competition and
market changes; and, failure to reach the intended synergies. Additional
discussion of these and other risks, uncertainties and factors affecting the
Company's business is contained in the Company's periodic filings with the
Securities and Exchange Commission. The reader should not place undue reliance
on forward-looking statements, since the statements speak only as of the date
that they are made. The Company undertakes no obligation to update
forward-looking statements to reflect changed assumptions, the occurrence of
unanticipated events or changes in future operating results, financial
condition or business over time.

CONTACT: Cerner Media Contact: Megan Moriarty,
         (816) 888-2470,
         Cerner Investors Contact: Allan Kells,
         (816) 201-2445,
Press spacebar to pause and continue. Press esc to stop.